Overview

Ph II Study of Azacitidine in Myelofibrosis

Status:
Completed

Trial end date:
2008-04-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical research study is to learn if azacitidine can help to control MF. The safety of azacitidine in patients with Myelofibrosis (MF) will also be studied.

Phase:

Phase 2

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborator:

Celgene Corporation

Treatments:

Azacitidine